The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.

Publications

Exhaled breath analysis for the detection of Streptococcus pneumoniae and Pseudomonas aeruginosa lung infections using gas chromatography - mass spectrometry: a rat model study.
Year: 
2018
Journal: 
EUROPEAN RESPIRATORY JOURNAL
van Oort, PMP; Brinkman, P; Slingers, G; Koppen, G; Maas, A; Roelofs, JJ; Schnabel, R; Bergmans, D; Goodacre, R; Fowler, S; Schultz, MJ; Bos, LD
Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium
Year: 
2018
Journal: 
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Felix, JF; Joubert, BR; Baccarelli, AA; Sharp, GC; Almqvist, C; Annesi-Maesano, I; Arshad, H; Baiz, N; Bakermans-Kranenburg, MJ; Bakulski, KM; Binder, EB; Bouchard, L; Breton, CV; Brunekreef, B; Brunst, KJ; Burchard, EG; Bustamante, M; Chatzi, L; Munthe-K

Pages